WST-1 Cell Proliferation Assay Reagent

WST-1 Cell Proliferation Assay Reagent
  • Contains sufficient reagents for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates
  • Can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues
  • Cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells
Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

CytoSelect™ WST-1 Cell Proliferation Assay Reagent
Catalog Number
CBA-253
Size
10 mL
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$335.00
Product Details

Cell Biolabs’ CytoSelect™ WST-1 Cell Proliferation Assay Reagent provides a colorimetric format for measuring and monitoring cell proliferation.  The 10 mL volume is sufficient for the evaluation of 960 assays in ten 96-well plates or 192 assays in eight 24-well plates.  Cells can be plated and then treated with compounds or agents that affect proliferation.  Cells are then detected with the proliferation reagent, which is converted in live cells from WST-1 to the formazan form in the presence of cellular NADH and an electron mediator.

An increase in cell proliferation is accompanied by increased signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions.  The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues.  This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells.

Human HEK 293 Cell Density. HEK 293 cells were seeded at various densities indicated above and allowed to grow for 24 hours. After adding the CytoSelect™ WST-1 Cell Proliferation Assay Reagent, cells were then incubated for 2 hours at 37ºC and 5% CO2.

Recent Product Citations
  1. Durmaz, B. et al. (2021). Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia. Biomed Res Int. doi: 10.1155/2021/3207328.
  2. Menini, S. et al. (2020). Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice. J Exp Clin Cancer Res. 39(1):152. doi: 10.1186/s13046-020-01665-0.
  3. Harada, H. et al. (2020). Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer. J Surg Res. 256:404-412. doi: 10.1016/j.jss.2020.07.001.
  4. Yokota, K. et al. (2019). WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability. Ann Surg Oncol. doi: 10.1245/s10434-019-07780-3.
  5. Harada, H. et al. (2019). Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer. PLoS One. 14(4):e0214872. doi: 10.1371/journal.pone.0214872.
  6. Woo, H.H. et al. (2019). Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. Biochim Biophys Acta Gene Regul Mech. 1862(1):35-46. doi: 10.1016/j.bbagrm.2018.10.008.
  7. Yang, Q. et al. (2018). PRKAA1/AMPKα1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis. Nat Commun. 9(1):4667. doi: 10.1038/s41467-018-07132-x.
  8. Yokoi, K. et al. (2018). Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy. Ann Surg Oncol. 26(2):406-414. doi: 10.1245/s10434-018-6865-z.